Testosterone (men)
Acute alcohol intake suppresses testosterone, measurable within hours. Chronic drinking (>7 drinks/week) is associated with 5-15% lower testosterone in observational studies. Mechanisms: direct testicular toxicity, impaired LH/FSH signaling, disturbed sleep, increased aromatization.
Estradiol
Alcohol impairs the liver's ability to clear estradiol from circulation. Result: effective E2 rises. In men, this contributes to high-E2 symptoms (water retention, gynecomastia risk, suppressed T). In perimenopausal women, it worsens estrogen-driven symptoms (heavier periods, breast tenderness).
Sleep architecture
Even small amounts of alcohol fragment sleep. The first half of the night may seem deeper, but REM is suppressed and the second half of the night is fragmented as alcohol metabolizes. Sleep tracker data consistently shows alcohol degrades sleep quality scores.
Liver enzymes
ALT, AST, GGT all rise with chronic alcohol consumption. GGT is particularly sensitive, rising before clinical liver disease becomes apparent. Reduction usually normalizes them within 4-8 weeks.
Blood pressure
Alcohol acutely raises blood pressure. Chronic drinking raises baseline. Each daily drink is associated with ~1 mmHg systolic increase on average.
Lipids and ApoB
Alcohol raises triglycerides, sometimes dramatically. ApoB rises modestly with regular drinking. HDL rises slightly with moderate alcohol (this was the "moderate drinking is healthy" basis), but the net effect on cardiovascular outcomes is unfavorable in modern analyses. See ApoB story.
Inflammation markers
hs-CRP and IL-6 rise with chronic drinking. Reduction lowers them within weeks.
Breast cancer (women)
The dose-response is linear. Each drink/day above zero raises breast cancer risk modestly but measurably. The Million Women Study showed each drink/day was associated with ~12% relative risk increase. For women with family history or prior breast cancer, alcohol reduction is meaningful.
Dose-response
Most negative effects scale with intake, there's not a "safe threshold" below which alcohol is neutral. Less is better. The "1-2 drinks per day is fine" framing isn't supported by current data; the truer statement is "less is better, none is best, but real-world tradeoffs make moderate drinking acceptable for many."
The clinical pearl: If your lab work shows low T (men), heavy periods (women), elevated GGT, high triglycerides, or rising ApoB, alcohol reduction is one of the highest-leverage interventions. Often the markers shift dramatically within 8-12 weeks of cutting back.
Bottom line
Alcohol moves almost every biomarker that matters in the unfavorable direction. The effects are dose-responsive, less is better. For health-optimizers, <3 drinks/week is the practical target. For anyone with low T, heavy periods, elevated lipids, or sleep complaints, alcohol reduction often produces measurable improvements that no other single intervention matches.